| Literature DB >> 34178360 |
Bailey Paterson1, Danielle E Fox2, Chel Hee Lee3, Victoria Riehl-Tonn4, Elena Qirzaji4, Rob Quinn2,4, David Ward4, Jennifer M MacRae4,5.
Abstract
BACKGROUND: Home hemodialysis (HHD) offers a flexible, patient-centered modality for patients with kidney failure. Growth in HHD is achieved by increasing the number of patients starting HHD and reducing attrition with strategies to prevent the modifiable reasons for loss.Entities:
Keywords: home hemodialysis; technique failure; training failure
Year: 2021 PMID: 34178360 PMCID: PMC8207266 DOI: 10.1177/20543581211022195
Source DB: PubMed Journal: Can J Kidney Health Dis ISSN: 2054-3581
Figure 1.Disposition of patients enrolled in home hemodialysis.
Note. HHD = home hemodialysis.
Patient Demographics.
| Variable | Non-tech failure | Tech failure | Overall | Train failure | ||
|---|---|---|---|---|---|---|
| n = 124 | n = 24 | n = 147 | ||||
| Sex | ||||||
| Male | 83 (67.5%) | 17 (70.8%) | 100 (68.0%) | 14 (70.0%) | ||
| Female | 40 (32.5%) | 7 (29.2%) | 47 (32.0%) | .93 | 6 (30.0%) | 1.00 |
| Age | ||||||
| Mean (SD) | 55.9 (12.4) | 60.7(16.4) | 56.7 (13.0) | 64.4(10.9) | .007 | |
| Vascular access | ||||||
| CVC | 70 (56.9%) | 12 (50%) | 82 (55.8%) | 12 (60.0%) | ||
| AVF | 53 (43.1%) | 12 (50%) | 65 (44.2%) | .54 | 8 (40.0%) | .91 |
| Relationship status | ||||||
| Single | 29 (23.6%) | 4 (16.7%) | 33 (22.4%) | 3 (15.0%) | ||
| Married | 72 (58.5%) | 16 (66.7%) | 88 (59.9%) | 13 (65.0%) | ||
| Common-law | 8 (6.5%) | 1 (4.2%) | 9 (6.1%) | 0 (0%) | ||
| Unknown | 14 (11.4%) | 3 (12.5%) | 17 (11.6%) | .89 | 4 (20.0%) | .56 |
| ESRD etiology | ||||||
| HTN | 20 (16.3%) | 3 (12.5%) | 23 (15.6%) | 9 (45.0%) | ||
| DM | 19 (15.4%) | 8 (33.3%) | 27 (18.4%) | 1 (5.0%) | ||
| RAS/ischemic | 5 (4.1%) | 1 (4.2%) | 6 (4.1%) | 1 (5.0%) | ||
| GN | 39 (31.7%) | 4 (16.7%) | 43 (29.3%) | 3 (15.0%) | ||
| PCKD | 20 (16.3%) | 2 (8.3%) | 22 (15.0%) | 1 (5.0%) | ||
| Obstructive | 2 (1.6%) | 0 (0%) | 2 (1.4%) | 0 (0%) | ||
| Other | 14 (11.4%) | 6 (25.0%) | 20 (12.6%) | 5 (25.0%) | ||
| Unknown | 4 (3.3%) | 0 (0%) | 4 (2.7%) | .22 | 0 (0%) | .05 |
| Comorbidities | ||||||
| CAD | 23 (18.7%) | 10 (41.7%) | 33 (22.4%) | .02 | 6 (30%) | .57 |
| DM | 38 (30.9%) | 11 (45.8%) | 49 (33.3%) | .17 | 7 (35.0%) | 1.00 |
| CHF | 17 (13.8%) | 6 (25%) | 23 (15.6%) | .19 | 9 (45.0%) | .004 |
| PVD | 13 (10.6%) | 6 (25%) | 19 (12.9%) | .08 | 1 (5.0%) | .47 |
| CVD | 10 (8.1%) | 3 (12.5%) | 13 (8.8%) | .50 | 5 (25.0%) | .045 |
| Cancer | 25 (20.3%) | 4 (16.7%) | 29 (19.7%) | .71 | 8 (40.0%) | .05 |
| Chronic pulmonary | 7 (5.7%) | 5 (20.8%) | 12 (8.2%) | .03 | 0 (0%) | .36 |
| >2 comorbidities | 74 (60.2%) | 18 (75%) | 92 (62.6%) | .18 | 19 (95.0%) | .009 |
Note. CVC = central venous catheter; AVF = arteriovenous fistula; ESRD = end-stage renal disease; HTN = hypertension; DM = diabetes mellitus; RAS = renal artery stenosis; GN = glomerulonephritis; PCKD = polycystic kidney disease; CHF = chronic heart failure; PVD = peripheral vascular disease; CVD = cardiovascular disease.
Patient Outcomes.
| Outcome | No. of patients | Train time median [IQR] | Time on HHD median [IQR] |
|---|---|---|---|
| Remaining on HHD | 80 (47.9 %) | 7.0 [5.1, 9.1] | 25 [14, 46] |
| Transplant | 35 (21%) | 5.1 [4.2, 7.1] | 17 [9.0, 32] |
| Death | 8 (4.8%) | 5.6 [5.4, 7.6] | 32 [18, 46] |
| Technique failure | 24 (14.4%) | 6.1 [4.5, 8.9] | 17 [8.9, 35] |
| Training failure | 20 (12%) | 3.1 [2.0, 5.5] | NA |
| All-comers | 167 (100%) | 6.0 [4.0, 8.4] | 23 [11, 41] |
Note. Time on HHD calculated only for the 147 patients who successfully completed training. IQR = inter-quartile range; HHD = home hemodialysis.
Train Failure Reasons.
| Exit reason (#) | Sub-categorization (#) | Train time median [IQR] (weeks) |
|---|---|---|
| Preference (6) | Excessive workload (2) | 2.8 [1.1, 4.2] |
| General weakness/lack of energy (1) | ||
| Close proximity to incentre dialysis location (1) | ||
| Lifestyle changes (1) | ||
| Undisclosed (1) | ||
| Medical (6) | Pulmonary disease (1) | 4.1 [3.1, 6.6] |
| Chronic pain (1) | ||
| Access site infection (1) | ||
| Burns with resultant hospitalization (1) | ||
| Intradialytic GI upset (2) | ||
| Death (2) | Sepsis (2) | 1.9 [1.4, 2.3] |
| Psychosocial (2) | Loss of support system (1) | 5.1 [3.6, 6.7 |
| Other (4) | Safety concerns raised by care team (1) | 3.9 [2.9, 5.1] |
| Arthritis with dexterity issues (1) | ||
| Visual impairment (1) | ||
| Electrical inadequacy of home (1) |
Note. IQR = inter-quartile range.
Hazard Ratios for Technique Failure Using the Competing Risk Model.
| Patient characteristic | Hazard ratio [95% CI] |
|---|---|
| Age | 1.02 [0.98-1.06] |
| Access type | 1.11 [0.50-2.43] |
| >2 comorbidities | 2.05 [0.82-5.13] |
| CAD | 2.67 [1.20-5.92] |
| DM | 2.20 [1.00-4.80] |
| CHF | 1.84 [0.73-4.66] |
| PVD | 2.16 [0.91-5.14] |
| CVD | 1.45 [0.44-4.77] |
| Cancer | 0.80 [0.27-2.38] |
| Pulmonary disease | 3.25 [1.17-9.03] |
Note. CAD = coronary artery disease; DM = diabetes mellitus; CHF = chronic heart failure; PVD = peripheral vascular disease; CVD = cardiovascular disease.
Categorization of Technique Failure.
| Exit reason (#) | Sub-categorization (#) | Train time median [IQR] | Time on home hemodialysis medial [IQR] |
|---|---|---|---|
| Medical (9) | Cognitive issues (2) | 7.0 | 18 |
| Intradialytic hypotension (1) | |||
| Palliation due to comorbid medical condition (1) | |||
| SOB due to comorbid medical condition (1) | |||
| Sepsis and hospitalization (1) | |||
| Prolonged hospital admission with rehabilitation (1) | |||
| Intradialytic GI 1symptoms (1) | |||
| Undisclosed (1) | |||
| Psychosocial (5) | Marital dissolution, loss of residence (1) | 8.0 | 13 |
| Eviction (1) | |||
| Loss of support system (2) | |||
| Fear of AVF needling (1) | |||
| Safety/adherence (3) | Cognitive issues (2) | 5.4 | 19 |
| Lab testing non-adherence (1) | |||
| Moved (6) | Interprovincial relocation (1) | 5.6 | 22 |
| Intraprovincial relocation (2) | |||
| Relocated countries (2) | |||
| Undisclosed destination (1) | |||
| Changed to PD (1) | Changed to PD (1) | 4.3 | 5.7 |
Figure 2.Competing risk curve for transplant, death, and technique failure.